Immersive Virtual Reality in Simulation-based Bronchoscopy Training
1 other identifier
interventional
35
1 country
1
Brief Summary
The purpose of this single-center randomized study is to investigate whether bronchoscopy training in an immersive Virtual Reality (iVR) environment will make the surgeon better at handling distractions and increase the quality of the bronchoscopy. The participants will be stratified according to gender and randomized into two groups. Both groups will initially train on the bronchoscopy simulator without VR. Afterwards the intervention group will train in an iVR environment with Virtual Reality Goggles while using the bronchoscopy simulator, while the control group will train without VR goggles. Afterwards both groups will be tested in the iVR environment in a test scenario
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2021
CompletedStudy Start
First participant enrolled
October 4, 2021
CompletedFirst Posted
Study publicly available on registry
October 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2022
CompletedMarch 9, 2022
March 1, 2022
4 months
September 22, 2021
March 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Structured Progress
The systematic visualization and structured passage through the bronchial tree measured in points (0-18 points)
From beginning to end of each procedure, aprox. 30 minutes
Procedure time
Time (seconds) from passing the vocal cords to retraction of the endoscope.
From beginning to end of each procedure, aprox. 30 minutes
Secondary Outcomes (6)
Motor Bronchoscopy Skill Score
From beginning to end of each procedure, aprox. 30 minutes
Diagnostic completeness
From beginning to end of each procedure, aprox. 30 minutes
Heart Rate Variability(LF/HF ratio)
From beginning to end of each procedure, aprox. 30 minutes
Eye movement measurements
From beginning to end of each procedure, aprox. 30 minutes
Eye movement measurements
From beginning to end of each procedure, aprox. 30 minutes
- +1 more secondary outcomes
Study Arms (2)
iVR
EXPERIMENTALThe intervention group will train on a bronchoscopy simulator in an iVR environment with Virtual Reality Goggles (HTC IVE Pro Eye, HTC corporation, Taiwan) while using the bronchoscopy simulator.
Non iVR
NO INTERVENTIONThe control group will train on a bronchoscopy simulator without VR goggles.
Interventions
Training in an iVR environment with Virtual Reality Goggles while using the bronchoscopy simulator, while the control group will train without VR goggles.
Eligibility Criteria
You may qualify if:
- Residents working in Denmark in thoracic surgery and pulmonary medicine
- Participants are required to have a medical license.
You may not qualify if:
- Previous participation in trials involving bronchoscopy training.
- Experience with independent bronchoscopy.
- No informed consent.
- Unable to speak Danish on a conversational level.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Copenhagen Academy for Medical Education and Simulation
Copenhagen, 2100, Denmark
Study Officials
- STUDY CHAIR
Lars Konge, Professor, MD, PHD
Copenhagen Academy for Medical Education and Simulation
- STUDY DIRECTOR
Flemming Bjerrum, MD, PhD
Copenhagen Academy for Medical Education and Simulation
- PRINCIPAL INVESTIGATOR
Annarita G Andersen, BMed
Copenhagen Academy for Medical Education and Simulation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- The participants will not be blinded to the main investigator, as this is impossible due to the nature of the trial. The statistical analysis will be performed blinded and by someone other than the principal investigator.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 22, 2021
First Posted
October 14, 2021
Study Start
October 4, 2021
Primary Completion
January 30, 2022
Study Completion
February 28, 2022
Last Updated
March 9, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share